HK206196A - Acid-labile subunit (ALS) of insulin-like-growth factor (IGF) binding protein complex - Google Patents
Acid-labile subunit (ALS) of insulin-like-growth factor (IGF) binding protein complexInfo
- Publication number
- HK206196A HK206196A HK206196A HK206196A HK206196A HK 206196 A HK206196 A HK 206196A HK 206196 A HK206196 A HK 206196A HK 206196 A HK206196 A HK 206196A HK 206196 A HK206196 A HK 206196A
- Authority
- HK
- Hong Kong
- Prior art keywords
- igf
- als
- acid
- binding protein
- insulin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4743—Insulin-like growth factor binding protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPI931488 | 1988-07-15 | ||
AUPJ335089 | 1989-03-23 | ||
PCT/AU1989/000299 WO1990000569A1 (fr) | 1988-07-15 | 1989-07-14 | Sous-unite labile aux acides d'un complexe proteique de liaison du facteur de croissance analogue a l'insuline |
Publications (1)
Publication Number | Publication Date |
---|---|
HK206196A true HK206196A (en) | 1996-11-22 |
Family
ID=25643507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK206196A HK206196A (en) | 1988-07-15 | 1996-11-14 | Acid-labile subunit (ALS) of insulin-like-growth factor (IGF) binding protein complex |
Country Status (8)
Country | Link |
---|---|
US (1) | US5936064A (fr) |
EP (1) | EP0424416B1 (fr) |
JP (4) | JP3178714B2 (fr) |
AT (1) | ATE125268T1 (fr) |
CA (1) | CA1341598C (fr) |
DE (1) | DE68923556T2 (fr) |
HK (1) | HK206196A (fr) |
WO (1) | WO1990000569A1 (fr) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE222117T1 (de) * | 1990-05-30 | 2002-08-15 | Harvard College | Kombination aus igf-i und tgf-beta zur knochenregenerierung |
US5212074A (en) * | 1990-08-28 | 1993-05-18 | Chiron Corporation | Genetic material encoding new insulin-like growth factor binding protein igfbp-6 |
CA2090703A1 (fr) * | 1990-08-28 | 1992-03-01 | Michael C. Kiefer | Proteine (igfbp-4) possedant une forte affinite pour un facteur de croissance de substances apparentees a l'insuline |
US6326154B1 (en) | 1990-11-19 | 2001-12-04 | Genentech, Inc. | Ligand-mediated immunofunctional hormone binding protein assay method |
US5210017A (en) * | 1990-11-19 | 1993-05-11 | Genentech, Inc. | Ligand-mediated immunofunctional hormone binding protein assay method |
FI86777C (fi) * | 1990-12-31 | 1992-10-12 | Medix Biochemica Ab Oy | Foerfarande foer diagnosticering av bristningen av fosterhinnorna samt reagensfoerpackning foer anvaendning daervid |
ATE247164T1 (de) * | 1991-01-08 | 2003-08-15 | Chiron Corp | Insulinartigen wachstumsfaktor bindendes protein |
US5187151A (en) * | 1991-02-12 | 1993-02-16 | Genentech, Inc. | Use of binding protein with igf-i as an anabolic growth promoting agent |
FI94181C (fi) | 1992-06-29 | 1995-07-25 | Medix Biochemica Ab Oy | Diagnostinen menetelmä synnytysajankohdan ennustamiseksi sekä siihen käytettävä reagenssipakkaus |
DE69333063T2 (de) | 1992-11-04 | 2004-05-13 | Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville | Vekürztes insulinähnlichen wachstumsfaktor-bindendes protein mit mitogener aktivität |
JPH09500088A (ja) * | 1993-01-29 | 1997-01-07 | アムジェン ボールダー インコーポレイテッド | 創傷治癒用組成物 |
US5994302A (en) * | 1994-12-09 | 1999-11-30 | Human Genome Sciences, Inc. | Human vascular IBP-like growth factor |
US5747280A (en) * | 1995-06-05 | 1998-05-05 | Human Genome Sciences, Inc. | Human vascular IBP-like growth factor |
AU715608B2 (en) * | 1996-03-20 | 2000-02-03 | Morphosys Ag | Purification of tissue plasminogen activator (tPA) |
GB2321191B (en) * | 1997-01-17 | 2000-09-27 | Johnson & Johnson Medical | Peptides for use in wound treatment |
AUPR030900A0 (en) | 2000-09-22 | 2000-10-12 | Queensland University Of Technology | Growth factor complex |
US6875570B2 (en) | 2000-09-27 | 2005-04-05 | Curagen Corporation | Proteins and nucleic acids encoding same |
WO2002026826A2 (fr) * | 2000-09-27 | 2002-04-04 | Curagen Corporation | Nouvelles proteines et acides nucleiques codant pour celles-ci |
US7153691B2 (en) * | 2002-11-13 | 2006-12-26 | G6 Science Corp. | Method of identifying and assessing DNA euchromatin in biological cells for detecting disease, monitoring wellness, assessing bio-activity, and screening pharmacological agents |
US20100143442A1 (en) | 2003-02-05 | 2010-06-10 | Queensland University Of Technology | Growth factor complexes and modulation of cell migration and growth |
AU2003900481A0 (en) | 2003-02-05 | 2003-02-20 | Queensland University Of Technology | Synthetic modulators of cell migration and growth |
AU2003903896A0 (en) | 2003-07-28 | 2003-08-07 | Queensland University Of Technology | Skin regeneration system |
WO2005033132A2 (fr) | 2003-10-03 | 2005-04-14 | Genentech, Inc. | Proteines de liaison a l'igf |
EP2507261B1 (fr) | 2009-11-30 | 2016-12-21 | Factor Therapeutics Limited | Chimères de fibronectine/facteur de croissance |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU627423B2 (en) * | 1987-04-06 | 1992-08-27 | Celtrix Pharmaceuticals, Inc. | Human somatomedin carrier protein subunits and process for producing them |
DK131988A (da) * | 1988-03-11 | 1989-09-12 | Erasmus University | Igf-bindingsprotein, dna-struktur, der koder for igf-bindingsproteinet og vektor indeholdende denne dna-struktur |
US5258287A (en) * | 1988-03-22 | 1993-11-02 | Genentech, Inc. | DNA encoding and methods of production of insulin-like growth factor binding protein BP53 |
JPH03504597A (ja) * | 1988-04-12 | 1991-10-09 | シナージェン,インコーポレーテッド | インスリン様成長因子活性の強化および阻害方法 |
US5324820A (en) * | 1988-07-15 | 1994-06-28 | Central Sydney Area Health Service | Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex |
US5258257A (en) * | 1991-09-23 | 1993-11-02 | Shipley Company Inc. | Radiation sensitive compositions comprising polymer having acid labile groups |
-
1989
- 1989-07-14 CA CA000605669A patent/CA1341598C/fr not_active Expired - Fee Related
- 1989-07-14 EP EP89907392A patent/EP0424416B1/fr not_active Expired - Lifetime
- 1989-07-14 DE DE68923556T patent/DE68923556T2/de not_active Expired - Lifetime
- 1989-07-14 WO PCT/AU1989/000299 patent/WO1990000569A1/fr active IP Right Grant
- 1989-07-14 JP JP50767289A patent/JP3178714B2/ja not_active Expired - Lifetime
- 1989-07-14 AT AT89907392T patent/ATE125268T1/de not_active IP Right Cessation
-
1995
- 1995-06-02 US US08/459,209 patent/US5936064A/en not_active Expired - Fee Related
-
1996
- 1996-11-14 HK HK206196A patent/HK206196A/xx not_active IP Right Cessation
-
2001
- 2001-01-26 JP JP2001018464A patent/JP2001252087A/ja active Pending
-
2003
- 2003-05-21 JP JP2003143508A patent/JP2003319791A/ja active Pending
-
2005
- 2005-01-05 JP JP2005000697A patent/JP2005118052A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO1990000569A1 (fr) | 1990-01-25 |
DE68923556D1 (de) | 1995-08-24 |
EP0424416B1 (fr) | 1995-07-19 |
JP2001252087A (ja) | 2001-09-18 |
JP2005118052A (ja) | 2005-05-12 |
JPH03506030A (ja) | 1991-12-26 |
ATE125268T1 (de) | 1995-08-15 |
JP3178714B2 (ja) | 2001-06-25 |
DE68923556T2 (de) | 1996-04-11 |
US5936064A (en) | 1999-08-10 |
CA1341598C (fr) | 2009-09-29 |
EP0424416A4 (en) | 1992-03-18 |
JP2003319791A (ja) | 2003-11-11 |
EP0424416A1 (fr) | 1991-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK206196A (en) | Acid-labile subunit (ALS) of insulin-like-growth factor (IGF) binding protein complex | |
HK1008400A1 (en) | Genetic modification of endothelial cells | |
ES2009590A6 (es) | Metodo de preparacion de proteina de cadena pesada del factor tisular humano. | |
NZ233451A (en) | Production of vascular endothelial growth factor and dna encoding same | |
ES8800987A1 (es) | Metodo de produccion del factor viii:c humano | |
HK166495A (en) | HIV-1 envelope muteins lacking hypervariable domains | |
EP1241258A3 (fr) | Facteur de stimulation de cellules souches | |
EP0575546A4 (en) | Prad1 cyclin and its cdna | |
CA2095153A1 (fr) | Modification genetique de cellules endotheliales | |
IE881755L (en) | Novel proteins with factor viii activity, process for their¹preparation using genetically engineered cells and¹pharmaceutical compositions containing them | |
AU6733487A (en) | Mammalian interleukin-4 | |
NZ237666A (en) | Hiv envelope (env) polypeptides, antibodies and compositions for treating aids | |
EP0833912A4 (fr) | Nouvelle cytokine de type facteur de croissance transformant tgf-beta | |
EP0219106A3 (fr) | Polypeptides induisant des anticorps contre le virus du SIDA | |
EP0216742A3 (fr) | Facteurs de croissance | |
ES8504938A1 (es) | Un metodo de producir una proteina interferon inmune humano | |
EP0559769A4 (en) | Heparin binding mitogen with homology to epidermal growth factor (egf) | |
EP0431541A3 (en) | Toxoplasma gondii antigen, its production and use | |
ES8504255A1 (es) | Procedimiento para la produccion de una hormona de crecimiento de porcino. | |
EP0182448A3 (fr) | Production de facteur VIII et produits apparentés | |
PT97383A (pt) | Processo para a producao de uma cadeia de globina, de um seu fragmento de ligacao e de hemoglobina, e de composicoes de hemoglobina | |
AU7939894A (en) | Recombinant pilc proteins, process for producing them and their use | |
EP0315118A3 (fr) | ADN codant pour endothéline et son utilisant | |
IL92685A0 (en) | Dna encoding lymphokine/cytokine like proteins,cells transformed thereby and production of said proteins and antibodies against them | |
ZA978503B (en) | Vertebrate smoothened proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PE | Patent expired |
Effective date: 20090713 |